4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-025251
Chief Technology Officer sold 20,000 shares at $10.34 ($206,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-04-19 | Sale | −20,000 | $10.34 | $206,800 | 8,122,803 | D |
| Open-market sales · 20,000 sh · avg $10.34 · $206,800 | |||||||
Loading xslF345X03/doc4.xml…